Products for
Initial Launch
Pain Cream
(P.A. Patent No. 62/530,878 and w THC/CBD P.A. Patent No. 62/407,996)
Reversing-slowing-repairing and reconstructing traumatic- &
stress-related damage while supporting the rapid relief from Pain: Phase I Efficacious pain relief is followed by Phase II anti-aging stem cell reorganization of extra-cellular matrix repair.
Communication: preventing pain signaling at the site of the origin from reaching the brain.
- Circumventing affective and sensory components of pain (neuro-synaptic blockade; a complex peptide regulates neurotransmitter chemistry blocking the pain signal).
- Topical Absorption, patented nanotechnology reduces the size of pain relieving molecules to one/one billionth of a meter, supporting rapid transmission of healing energy through tissues layers to an inflamed site, promoting restoration of pain-free physiology
- The use of regenerative medicine aids with the repair and reorganization of damaged tissue, inflammation and restores cellular communication.
- Within seconds, the topical formula provides the user with gratifying relief
112